TABLE 1.
Peptide a | Transcription activation b (Miller units/109 cells) | Binding affinities (KD c in μM) |
---|---|---|
C13 (WT) | 215 ± 5 | 6.6 ± 0.3 |
S14A | 105 ± 5 | 8.1 ± 0.9 |
E15A | 107 ± 2.5 | 3.3 ± 0.1 |
W16A | 7.5 ± 2.5 | 50.0 ± 3.6 |
V17A | 6 ± 1 | 9.7 ± 0.6 |
I18A | 7.5 ± 1.5 | >100 |
V19A | 215 ± 5 | 4.0 ± 0.8 |
I20A | 8.5 ± 0.5 | 23.54 |
P21A | 7.5 ± 2.5 | 1.7 ± 0.1 |
F22A | 90 ± 10 | 7.1 ± 0.4 |
L23A | 95 ± 5 | 4.3 ± 0.2 |
T24A | 175 ± 5 | 3.3 ± 0.1 |
N25A | 185 ± 5 | 3.3 ± 0.2 |
L26A | 182 ± 2.5 | 3.4 ± 0.3 |
WT C13 or modified peptides were used. The numbers show the position of alanine replacement within the full‐length Shp144.
Mean ± SEM of three independent experiments.
Dissociation constant between the Rgg144 and its ligand SHP144.